Human cells require O-2 for many metabolic processes, most notably oxi
dative phosphorylation, the major source of ATP generation, and hypoxi
a plays a significant pathophysiologic role in a variety of cardiovasc
ular disorders. Hypoxia-inducible factor I (HIF-1) is a transcriptiona
l activator of genes whose products, including erythropoietin, vascula
r endothelial growth factor, and glycolytic enzymes, are involved in s
ystemic, local, and cellular responses to hypoxia that either increase
O-2 delivery or induce alternative metabolic pathways that do not req
uire O-2. The level of HIF-1 expression in cultured cells is proportio
nal to the degree of hypoxia over the range of O-2 concentrations asso
ciated with physiologic and pathophysiologic conditions in vivo. Furth
er investigation of HIF-1 function in vivo may lead to novel therapeut
ic approaches that modulate cellular responses to hypoxia/ischemia.